This inventor holds 2 USPTO granted patents. Top assignees: Pohang University of Science and Technology Foundation, Posco. Active years: 2013-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2014
Title: Young-Chan Chae: Innovator in Aptamer Technology
Introduction
Young-Chan Chae is a prominent inventor based in Pohang-si, South Korea. He has made significant contributions to the field of aptamer technology, holding a total of 2 patents. His work focuses on developing methods for identifying aptamers that can bind to specific target molecules, which has important implications in diagnostics and therapeutics.
Latest Patents
One of his latest patents is titled "Aptamer Sandwich Assays." This invention provides methods for identifying a plurality of aptamers that bind to different sites of a target molecule. The methods can be utilized in sandwich assays, where aptamers are identified from a library generated through the SELEX process. Another notable patent is "Nucleolin Specific Aptamer and Use Thereof." This patent describes improved G-rich oligonucleotide (GRO) aptamers that are specific to nucleolin. It also outlines a method for preparing these aptamers and their potential use in diagnosing and treating nucleolin-associated diseases.
Career Highlights
Throughout his career, Young-Chan Chae has worked with esteemed organizations such as the Postech Academy-Industry Foundation and Posco. His experience in these institutions has allowed him to advance his research and contribute to the field of biotechnology.
Collaborations
Young-Chan Chae has collaborated with notable colleagues, including Youn-Dong Kim and Jung-Hwan Lee. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Young-Chan Chae is a distinguished inventor whose work in aptamer technology has the potential to revolutionize diagnostics and treatment options. His contributions are paving the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile